Research & Publications
Dr. Lipska is an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). Her research program seeks to better understand the balance of benefits and harms of glucose-lowering therapy in older adults with type 2 diabetes. Her current research projects are primarily focused on severe hypoglycemia. She is investigating trends in admissions for hypoglycemia among the elderly Medicare population; race, sex, and age disparities in these admissions; using qualitative research methods to explore reasons for hypoglycemia admissions; examining key risk factors for hypoglycemia; and developing prediction models for hypoglycemia. Based on these data, she seeks to develop and implement decision support tools to help clinicians and patients make better decisions about their care. Her overall goals are to generate data that patients and clinicians need—data which currently do not exist—so that they can make better, smarter treatment decisions.
In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.
YCCI Scholar 2013
Project: 11/01/13 - 10/31/15
Treatment-Related Determinants of SevereHypoglycemia in Type 2 Diabetes
Education & Training
- Fogarty International Clinical Research FellowshipPublic Health Foundation of India (2012)
- MHSYale University School of Medicine, Robert Wood Johnson Clinical Scholars Program (2011)
- FellowshipYale University School of Medicine (2009)
- ResidencyBrigham and Women's Hospital (2006)
- MDHarvard Medical School (2003)
- BSYale University, Molecular Biochemistry and Biophysics (1997)
- Diabetes Care in Older AdultsLos Angeles, CA, United States 2019UCLA Endocrine Grand Rounds, "Diabetes Care for Older Adults"
- The Insulin Racket – Why Is A Century-Old Drug Still So Expensive and What Can We Do About It?Portland, OR, United States 2019Victor and Betty Rosenfeld Memorial Lecture, Medical Grand Rounds
- Diabetes Management on a BudgetAlbuquerque, NM, United States 2019Project ECHO
- The Insulin Racket – Why is a Century-Old Drug Still So Expensive and What Can We Do About It?New York, NY, United States 2019Albert Einstein Endocrine Grand Rounds
- Human insulin for type 2 diabetes: Observational data on safety and effectivenessKraków, Lesser Poland Voivodeship, Poland 2019XI Małopolskie Dni Diabetologiczne
- The Insulin Cost ScandalWorcester, MA, United States 2019University of Massachusetts, Endocrine Grand Rounds
- Hypoglycemia During Treatment of Type 2 DiabetesNew York, NY, United States 2018Naomi Berrie Diabetes Center, Columbia University Medical Center
- Use of Real-World Data for Surveillance and MonitoringWashington, DC, United States 2018American Diabetes Association Research Symposium
- Break Up the Insulin RacketNew York, NY, United States 2018Albert Einstein College of Medicine, Internal Medicine Interest Group Seminar
- Hypoglycemia in Patients with Type 2 Diabetes MellitusPhiladelphia, PA, United States 2018University of Pennsylvania School of Medicine, Center for Clinical Epidemiology & Biostatistics Seminar Series
- Hypoglycemia During Treatment of DiabetesOrlando, FL, United States 2018American Geriatrics Society 2018 Annual Scientific Meeting
- Diabetes Research in IndiaIndia (2011-2012)As a Fogarty International Clinical Research Fellow, Dr. Lipska studied the prevalence of undiagnosed diabetes, pre-diabetes, and levels of insulin resistance among patients with ischemic stroke in Trivandrum and New Delhi, India.
|National Public Radio, The People's Pharmacy, "How is diabetes diagnosed and treated"||Presenter/Speaker||2019|
|U.S. House Committee on Energy & Commerce Hearing on “Priced out of a life-saving drug: The human impact of rising insulin prices"||Hearing on “Priced out of a life-saving drug: The human impact of rising insulin prices."||2019|
|National Public Radio, "Insulin Has Become Unaffordable. Patients Are Dying In Their Efforts To Ration Doses"||Insulin Has Become Unaffordable. Patients Are Dying In Their Efforts To Ration Doses||2019|
|Endocrine Section Gender Equity Committee||Committee Member||2018 - Present|
|Diabetes UK, Harry Keen Intermediate Clinical Fellowship||Ad hoc reviewer for Diabetes UK, Harry Keen Intermediate Clinical Fellowship||2017|